Cromogranina a sierica nel cancro della prostata Risultati preliminari

Minerva Medica

Volumn 90, Issue 7-8, 1999, Pages 221-223

  Kkalf, M G ^a   Marchfi, G G ^b   Bocca, S ^a   Cristofolftti, C ^a   Caporossi, F ^b   Marchfi, M ^a   Izzo, P ^a   Marchfi, P ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; CANCER HORMONE THERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MALE; PROSTATE CANCER;

AGED; CHROMOGRANIN A; CHROMOGRANINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033395528     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Abrahamsson PA, Falkmer S, Fait K, Grimelius L. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an endocrine marker. Path Res Pract 1989:185:373.
2. Cussenot O, Villette JM. Valeri A, and Le Duc A. Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma. J Urol 1996:155:1340.
3. Deftos LJ, Nakada S, Burton DW, Abrahamsson PA. limmunoassay and immunohstoology studies of chromogranin A as a neuroendocrine marker in patients with carcinma of the prostate. Adult urology 1996:481(1):58.
4. Kadmon D, Thompson TC. Lynch GR, Scardino PT. Elevated plasma chromogranin- a concentrations in prostatic carcinoma. J Urol 1991;146:358.
5. O'Connor DT. Deftos LJ. Secretion of chromogranin A bt peptide- producing endocrine neoplasms. N Kngl J Med 1986:314:1145.